| 801 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
77 |
| 802 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
23 |
| 803 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Germany |
58 |
| 804 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
53 |
| 805 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Germany |
75 |
| 806 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
61 |
| 807 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
8 |
| 808 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
63 |
| 809 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Ukraine |
38 |
| 810 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Germany |
70 |
| 811 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
USA |
69 |
| 812 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
31 |
| 813 |
Bone Marrow Family |
Allogeneic
|
Acute Myleogenous Leukemia, alloPBST 7/2025
|
Hematology
|
2025
|
Standard Therapy |
Germany |
53 |
| 814 |
Bone Marrow |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Spain |
15 |
| 815 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Norway |
55 |
| 816 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy |
France |
3 |
| 817 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
7 |
| 818 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Ukraine |
36 |
| 819 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy |
France |
10 |
| 820 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
USA |
76 |
| 821 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
39 |
| 822 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
South Africa |
6 |
| 823 |
Bone Marrow |
Allogeneic
|
Wiskott-Aldrich syndrome
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
6 |
| 824 |
Bone Marrow |
Allogeneic
|
Combined immnunodeficiency
|
Hematology
|
2025
|
Standard Therapy |
Ukraine |
3 |
| 825 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2025
|
Standard Therapy |
Poland |
3 |
| 826 |
Bone Marrow |
Allogeneic
|
Mixed Phenotype Acute Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
13 |
| 827 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
7 |
| 828 |
Bone Marrow |
Allogeneic
|
B-cell precursor Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
56 |
| 829 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
43 |
| 830 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Poland |
19 |
| 831 |
Bone Marrow |
Allogeneic
|
Very Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
12 |
| 832 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
5 |
| 833 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
10 |
| 834 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
6 |
| 835 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
44 |
| 836 |
Bone Marrow |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria
|
Hematology
|
2025
|
Standard Therapy |
Poland |
25 |
| 837 |
Bone Marrow |
Allogeneic
|
Juvenile Myelomonocytic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
4 |
| 838 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
21 |
| 839 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
12 |
| 840 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Hungary |
10 |
| 841 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Czechia |
68 |
| 842 |
Bone Marrow |
Allogeneic
|
Adrenoleukodystrophy
|
Hematology
|
2025
|
Standard Therapy |
Poland |
53 |
| 843 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
4 |
| 844 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
France |
4 |
| 845 |
Bone Marrow |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria
|
Hematology
|
2025
|
Standard Therapy |
Norway |
18 |
| 846 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Spain |
24 |
| 847 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Belarus |
5 |
| 848 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
53 |
| 849 |
Bone Marrow |
Allogeneic
|
diamond-Balckfan anemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
11 |
| 850 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
57 |
| 851 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
61 |
| 852 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
France |
3 |
| 853 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Belarus |
1 |
| 854 |
Bone Marrow |
Allogeneic
|
pB-Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
15 |
| 855 |
Bone Marrow |
Allogeneic
|
OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein
|
Hematology
|
2025
|
Standard Therapy |
Switzerland |
2 |
| 856 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
46 |
| 857 |
Bone Marrow |
Allogeneic
|
Acquired Idiopathic Sideroblastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Russian Federation |
5 |
| 858 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
10 |
| 859 |
Bone Marrow |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2025
|
Standard Therapy |
USA |
47 |
| 860 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
CROATIA |
11 |
| 861 |
Bone Marrow |
Allogeneic
|
Juvenile myelomonocytic leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
5 |
| 862 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Brazil |
12 |
| 863 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Australia |
8 |
| 864 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
3 |
| 865 |
Bone Marrow |
Allogeneic
|
Myelodysplatic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
USA |
60 |
| 866 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Russia |
36 |
| 867 |
Bone Marrow |
Allogeneic
|
Thalassemia major
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
10 |
| 868 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
58 |
| 869 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
2 |
| 870 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
18 |
| 871 |
Bone Marrow |
Allogeneic
|
Other Non-Malignant Disease, Specify
|
Hematology
|
2025
|
Standard Therapy |
USA |
17 |
| 872 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
15 |
| 873 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
15 |
| 874 |
Bone Marrow |
Allogeneic
|
aplastic anemia
|
Hematology
|
2025
|
Standard Therapy |
Belgium |
36 |
| 875 |
Bone Marrow |
Allogeneic
|
Primary Refractory
|
Hematology
|
2025
|
Standard Therapy |
Ireland |
27 |
| 876 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
39 |
| 877 |
Bone Marrow |
Allogeneic
|
Sickle Cell Disease (SCD)
|
Hematology
|
2025
|
Standard Therapy |
Italy |
8 |
| 878 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
68 |
| 879 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
58 |
| 880 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
1 |
| 881 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
13 |
| 882 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Denmark |
38 |
| 883 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
17 |
| 884 |
Bone Marrow |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
11 |
| 885 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
9 |
| 886 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
3 |
| 887 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
9 |
| 888 |
Bone Marrow |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
8 |
| 889 |
Bone Marrow |
Allogeneic
|
Immune Deficiency
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
10 |
| 890 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
12 |
| 891 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
20 |
| 892 |
Bone Marrow |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
17 |
| 893 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
13 |
| 894 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Canada |
22 |
| 895 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
15 |
| 896 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
8 |
| 897 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy |
France |
3 |
| 898 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
2 |
| 899 |
Bone Marrow |
Allogeneic
|
Bone Marrow Failure
|
Hematology
|
2025
|
Standard Therapy |
Netherlands |
23 |
| 900 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2025
|
Standard Therapy |
Italy |
6 |